Skip to content

Drug interactions

Everolimus + Metformin-sitagliptin

Severity: Moderate

Everolimus and Metformin-sitagliptin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Everolimus commonly causes hyperglycemia and hyperlipidemia, which can work against the glucose-lowering action of antidiabetic therapy. Patients with diabetes may need intensification of their treatment while on everolimus.

What this interaction means in plain words

Everolimus and Metformin-sitagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Everolimus belongs to Oncology; Metformin-sitagliptin belongs to Endocrine.

Evidence level: Moderate

Why it happens

mTOR inhibition by everolimus induces insulin resistance and reduces pancreatic beta-cell function, opposing the glucose-lowering effect of metformin and sitagliptin.

What to do

Monitor fasting glucose and HbA1c at baseline and regularly during everolimus therapy, and adjust antidiabetic therapy as needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Everolimus and Metformin-sitagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Everolimus with Metformin-sitagliptin?

MediHelp rates the interaction as moderate. Everolimus and Metformin-sitagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Everolimus commonly causes hyperglycemia and hyperlipidemia, which can work against the glucose-lowering action of antidiabetic therapy. Patients with diabetes may need intensification of their treatment while on everolimus.

How serious is the interaction between Everolimus and Metformin-sitagliptin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor fasting glucose and HbA1c at baseline and regularly during everolimus therapy, and adjust antidiabetic therapy as needed.

What other medicines interact with Metformin-sitagliptin?

MediHelp also lists interactions of Metformin-sitagliptin with, for example, Clozapine, Contrast media, Diatrizoate meglumine / diatrizoate. The full list is on the Metformin-sitagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in